| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880fdd58fb74dc19b8025af4de7153af |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-196 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a034217360b6ed119a065f34d4c80ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48593f03459c952374a3f6a000db07f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69fc7600d17cab5ecf7a7678cd024c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85d4862f8c35b8909bb50c133e01172f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77df78ffe3a1680e47195c94323a57f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_424ea2d2275f455e37d981c698ec20c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae94c559adab37ed11b94dce8c6e8f3 |
| publicationDate |
2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2390261-A2 |
| titleOfInvention |
Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
| abstract |
The present invention provides a modified human thrombopoietin polypeptide fragment that has platelet proliferative activity in vivo and in vitro and enhanced resistance to protease existing in vivo. |
| priorityDate |
2009-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |